Preliminary results show that FAP targeted positron emission molecular imaging probes accumulate in sarcoma, esophageal cancer, breast cancer, cholangiocarcinoma, and lung cancer with a standardized uptake value (SUV) over 12. Here, FAP is linked to breast carcinoma.